Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.08), $0.06 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $66 million versus the consensus estimate of $53.58 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.